EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and anti-tumor evaluation of indolin-2-one derivatives based on 3D-QSAR

Xingdan Wang, Liying Zhang, Ziqi He, Xinyue Li, Jing Bai, Qidi Zhong

Bioorganic & Medicinal Chemistry Letters · 2026-07 · 136 · 130618

DOI: 10.1016/j.bmcl.2026.130618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026-07. Verfasst von Xingdan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China. Hauptthemen laut MEDLINE: Indoles, Quantitative Structure-Activity Relationship, Antineoplastic Agents, Drug Design. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Tangshan Science and Technology Bureau, University of Science and Technology of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tropomyosin receptor kinase (TRK) plays a critical role in tumorigenesis, and its aberrant activation is strongly implicated in cancer progression and metastasis. In this study, a series of novel indoline-2-one derivatives were designed and synthesized using a 3D-QSAR-guided approach targeting TRK. The antitumor potential of these compounds was evaluated through a panel of in vitro bioassays. Several derivatives were found to reduce TRK phosphorylation levels in a cellular context and exhibited pronounced anti-proliferative and anti-migratory effects. Among them, compound IIIc demonstrated potent activity against HepG2 hepatocellular carcinoma cells, with an IC₅₀ value of 2.06 μM. Furthermore, ELISA-based phosphorylation assays revealed that treatment with compound IIIc resulted in decrease in TRK phosphorylation, yielding an IC₅₀ of 0.19 μM, highlighting its therapeutic promise. Collectively, this study provides experimental evidence and a structural basis for the development of lead compounds capable of modulating TRK signaling in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesQuantitative Structure-Activity RelationshipAntineoplastic AgentsDrug DesignProtein Kinase InhibitorsHumansCell ProliferationDrug Screening Assays, AntitumorHep G2 CellsMolecular Docking SimulationMolecular StructurePhosphorylationDose-Response Relationship, DrugReceptor, trkA

Stichwörter der Autor:innen

3D-QSARAntitumor activityIndolin-2-one derivativesMolecular docking

Substanzen

IndolesAntineoplastic Agentsindolin-2-oneProtein Kinase InhibitorsReceptor, trkA

Autor:innen und Institutionen

  • School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China.
  • School of Basic Medicine, North China University of Science and Technology, Tangshan 063210, China. Electronic address: baijing7858@163.com.
  • School of Pharmacy, North China University of Science and Technology, Tangshan 063210, China. Electronic address: qidizhong@ncst.edu.cn.

Förderung

  • Tangshan Science and Technology Bureau
  • University of Science and Technology of China

Zitieren

APA

Wang, X., Zhang, L., He, Z., Li, X., Bai, J., & Zhong, Q. (2026). Design, synthesis, and anti-tumor evaluation of indolin-2-one derivatives based on 3D-QSAR. Bioorganic & Medicinal Chemistry Letters, 136, 130618. https://doi.org/10.1016/j.bmcl.2026.130618

Vancouver

Wang X, Zhang L, He Z, Li X, Bai J, Zhong Q. Design, synthesis, and anti-tumor evaluation of indolin-2-one derivatives based on 3D-QSAR. Bioorganic & Medicinal Chemistry Letters. 2026;136:130618. doi:10.1016/j.bmcl.2026.130618

BibTeX
@article{Wang2026,
  author = {Wang, Xingdan and Zhang, Liying and He, Ziqi and Li, Xinyue and Bai, Jing and Zhong, Qidi},
  title = {Design, synthesis, and anti-tumor evaluation of indolin-2-one derivatives based on 3D-QSAR},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  volume = {136},
  pages = {130618},
  doi = {10.1016/j.bmcl.2026.130618}
}
Kostenlos starten →